Figure 2 | British Journal of Cancer

Figure 2

From: Proteomic identification of secreted proteins as surrogate markers for signal transduction inhibitor activity

Figure 2

(A) Western blot to determine PDI levels in conditioned media of A431 cells treated with, track 1, no treatment; track 2, DMSO control; track 3, 5 × 10−6M Gefitinib; track 4, DMSO control; track 5, 1 × 10−5M. (B) Image analysis of the density of the autoradiographic signal expressed in arbitrary units: 1, no treatment; 2, DMSO control; 3, 5 × 10−6M Gefitinib; 4, DMSO control; 5, 1 × 10−5M.

Back to article page